ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.517,68
-0,69%
S&P 500
5.352,96
-0,02%
Dow Jones
38.886,17
0,20%
Euro vs US Dollar
1,08932
0,02%
Bitcoin
71.300,02
0,76%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Repro Med Systems Inc (REPR)

  7. Repro Med Systems Inc (REPR) News

REPR

Repro Med Systems (REPR)

Repro Med Systems Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:REPR
DatumZeitQuelleÜberschriftSymbolFirma
26/05/202018h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPRRepro Med Systems Inc
21/05/202012h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:REPRRepro Med Systems Inc
14/05/202014h40Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:REPRRepro Med Systems Inc
14/05/202014h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPRRepro Med Systems Inc
11/05/202023h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
07/05/202023h05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:REPRRepro Med Systems Inc
06/05/202022h34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REPRRepro Med Systems Inc
05/05/202014h30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPRRepro Med Systems Inc
30/04/202014h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPRRepro Med Systems Inc
24/04/202022h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPRRepro Med Systems Inc
14/04/202022h51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPRRepro Med Systems Inc
01/04/202023h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
01/04/202022h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
01/04/202022h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
01/04/202022h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
01/04/202022h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
01/04/202022h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
01/04/202022h45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
31/03/202019h55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:REPRRepro Med Systems Inc
12/03/202022h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:REPRRepro Med Systems Inc
12/03/202011h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:REPRRepro Med Systems Inc
06/03/202022h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REPRRepro Med Systems Inc
04/03/202023h11Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:REPRRepro Med Systems Inc
04/03/202022h58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REPRRepro Med Systems Inc
25/02/202022h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:REPRRepro Med Systems Inc
25/02/202022h51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPRRepro Med Systems Inc
14/02/202023h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPRRepro Med Systems Inc
29/01/202023h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPRRepro Med Systems Inc
29/01/202023h17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REPRRepro Med Systems Inc
24/01/202022h40Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:REPRRepro Med Systems Inc
 Showing the most relevant articles for your search:NASDAQ:REPR

Kürzlich von Ihnen besucht

BOV
D2PZ34
Dominos Pizza
BIT
UV8DAM
UniCredit Bank
BIT
SVIS5S
Societe Generale Effekten
BIT
P1USZ8
NLBNPIT1USZ8 20991231 11...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten